Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IONQ Inc (IONQ) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

IONQ Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? IONQ Inc trades at $39.9 (market cap $15.98B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 33 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.

IONQROIV
Market Cap
$15.98B$24.72B
Volume
22,848,2406,279,442
Sector
TechnologyHealth
52-Week High
$82.09$41.81
52-Week Low
$26.59$16.04
Typical Hold Time
33 Days1 Days
Enterprise Value
$13.92B$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IONQ Inc

IONQ trades at $39.89, down 3.51% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported revenue of $130.02M in 2025 but a net loss of $510.38M, with a high P/S ratio of 54.74. Recent news highlights Bank of America's Buy rating and $60 price target, citing IonQ's semiconductor-based quantum computing approach as a key growth driver.

The stock presents high-risk, high-reward potential with strong analyst optimism but faces significant execution risks amid widening losses. Upside depends on scaling quantum technology profitably, while downside risks include cash burn and competitive threats. The consensus price target of $62.75 suggests substantial upside if growth targets are met.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONQ
81% Buy19% Sell
Avg holding period · 33 Days
ROIV

No sentiment data available yet.

About IONQ Inc

IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.

Read more on IONQ →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →